In vivo human Cartilage Oligomeric Matrix Protein (COMP) promoter activity

Matrix Biology

Volumn 24, Issue 8, 2005, Pages 539-549

  Posey, Karen L ^a   Davies, Sherri ^b   Bales, Elise S ^a   Haynes, Richard ^c   Sandell, Linda J ^b   Hecht, Jacqueline T ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Shriners Hospital for Children   (United States)

Author keywords

COMP; Dwarfism; Promoter; Pseudoachondroplasia; Skeleton

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CARTILAGE; CELL LINE; CHONDROSARCOMA; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; EVALUATION; EYE DEVELOPMENT; FIBROBLAST; FUSION GENE; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIMB DEVELOPMENT; LONG BONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; RNA TRANSLATION; SPINE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; EMBRYO; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOPROTEINS; HIGH MOBILITY GROUP PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 28244435801     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2005.07.007     Document Type: Article

References (41)

1. J.C. Adams Thrombospondins: multifunctional regulators of cell interactions Annu. Rev. Cell Dev. Biol. 17 2001 25 51
2. J. Adams, R.P. Tucker, and J. Lawler The Thrombospondin Gene Family 1995 Springer-Verlag N.Y.
3. H. Akiyama, M.C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe The transcription factor sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of sox5 and sox6 Genes Dev. 16 21 2002 2813 2828
4. W. Bi, J.M. Deng, Z. Zhang, R.R. Behringer, and B. de Crombrugghe Sox9 is required for cartilage formation Nat. Genet. 22 1 1999 85 89
5. M. Blanchette, W.J. Kent, C. Riemer, L. Elnitski, A.F. Smit, K.M. Roskin, R. Baertsch, K. Rosenbloom, H. Clawson, E.D. Green, D. Haussler, and W. Miller Aligning multiple genomic sequences with the threaded blockset aligner Genome Res. 14 4 2004 708 715
6. L.C. Bridgewater, V. Lefebvre, and B. de Crombrugghe Chondrocyte-specific enhancer elements in the col11a2 gene resemble the col2a1 tissue-specific enhancer J. Biol. Chem. 273 24 1998 14998 15006
7. L.C. Bridgewater, M.D. Walker, G.C. Miller, T.A. Ellison, L.D. Holsinger, J.L. Potter, T.L. Jackson, R.K. Chen, V.L. Winkel, Z. Zhang, S. McKinney, and B. de Crombrugghe Adjacent DNA sequences modulate sox9 transcriptional activation at paired sox sites in three chondrocyte-specific enhancer elements Nucleic Acids Res. 31 5 2003 1541 1553
8. M.D. Briggs, S.M. Hoffman, L.M. King, A.S. Olsen, H. Mohrenweiser, J.G. Leroy, G.R. Mortier, D.L. Rimoin, R.S. Lachman, E.S. Gaines, J.A. Cekleniak, R.G. Knowlton, and D.H. Cohn Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene Nat. Genet. 10 3 1995 330 336
9. H. Chen, M. Deere, J.T. Hecht, and J. Lawler Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes J. Biol. Chem. 275 34 2000 26538 26544
10. F. Chiaromonte, V.B. Yap, and W. Miller Scoring pairwise genomic sequence alignments Pac. Symp. Biocomput. 2002 115 126
11. R.R. Cooper, I.V. Ponseti, and J.A. Maynard Pseudoachondroplasia dwarfism. A rough-surfaced endoplasmic reticulum disorder J. Bone Jt. Surg., Am. Vol. 55A 1973 475 484
12. O. Couronne, A. Poliakov, N. Bray, T. Ishkhanov, D. Ryaboy, E. Rubin, L. Pachter, and I. Dubchak Strategies and tools for whole-genome alignments Genome Res. 13 1 2003 73 80
13. B. de Crombrugghe, V. Lefebvre, R.R. Behringer, W. Bi, S. Murakami, and W. Huang Transcriptional mechanisms of chondrocyte differentiation Matrix Biol. 19 5 2000 389 394
14. B. de Crombrugghe, V. Lefebvre, and K. Nakashima Regulatory mechanisms in the pathways of cartilage and bone formation Curr. Opin. Cell Biol. 13 6 2001 721 727
15. M. Deere, C. Rhoades Hall, K.B. Gunning, V. LeFebvre, A.L. Ridall, and J.T. Hecht Analysis of the promoter region of human cartilage oligomeric matrix protein (comp) Matrix Biol. 19 8 2001 783 792
16. P. DiCesare, N. Hauser, D. Lehman, S. Pasumarti, and M. Paulsson Cartilage oligomeric matrix protein (comp) is an abundant component of tendon FEBS Lett. 354 2 1994 237 240
17. C. Fang, C.S. Carlson, M.P. Leslie, H. Tulli, E. Stolerman, R. Perris, L. Ni, and P.E. Di Cesare Molecular cloning, sequencing, and tissue and developmental expression of mouse cartilage oligomeric matrix protein (comp) J. Orthop. Res. 18 4 2000 593 603
18. R.S. Fife, and K.D. Brandt Identification of a high-molecular-weight (greater than 400 000) protein in hyaline cartilage Biochim. Biophys. Acta 802 3 1984 506 514
19. F. Han, J.R. Kipnes, Y. Li, R.S. Tuan, and D.J. Hall The murine comp (cartilage oligomeric matrix protein) promoter contains a potent transcriptional repressor region Osteoarthr. Cartil. 10 8 2002 638 645
20. N. Hauser, M. Paulsson, A.A. Kale, and P.E. DiCesare Tendon extracellular matrix contains pentameric thrombospondin-4 (tsp-4) FEBS Lett. 368 2 1995 307 310
21. J.T. Hecht, L.D. Nelson, E. Crowder, Y. Wang, F.F. Elder, W.R. Harrison, C.A. Francomano, C.K. Prange, G.G. Lennon, M. Deere, and J. Lawler Mutations in exon 17b of cartilage oligomeric matrix protein (comp) cause pseudoachondroplasia Nat. Genet. 10 3 1995 325 329
22. J.T. Hecht, M. Deere, E. Putnam, W. Cole, B. Vertel, H. Chen, and J. Lawler Characterization of cartilage oligomeric matrix protein (comp) in human normal and pseudoachondroplasia musculoskeletal tissues Matrix Biol. 17 4 1998 269 278
23. J.T. Hecht, D. Montufar-Solis, G. Decker, J. Lawler, K. Daniels, and P.J. Duke Retention of cartilage oligomeric matrix protein (comp) and cell death in redifferentiated pseudoachondroplasia chondrocytes Matrix Biol. 17 8-9 1998 625 633
24. J.T. Hecht, O. Makitie, E. Hayes, R. Haynes, M. Susic, D. Montufar-Solis, P.J. Duke, and W.G. Cole Chondrocyte cell death and intracellular distribution of comp and type ix collagen in the pseudoachondroplasia growth plate J. Orthop. Res. 22 4 2004 759 767
25. J. Hou, J.A. Putkey, and J.T. Hecht Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (comp) disrupts calcium binding Cell Calcium 27 6 2000 309 314
26. P.S. Issack, C. Fang, M.P. Leslie, and P.E. Di Cesare Chondrocyte-specific enhancer regions in the comp gene J. Orthop. Res. 18 3 2000 345 350
27. P.S. Issack, C.J. Liu, L. Prazak, and P.E. Di Cesare A silencer element in the cartilage oligomeric matrix protein gene regulates chondrocyte-specific expression J. Orthop. Res. 22 4 2004 751 758
28. M. Kvansakul, J.C. Adams, and E. Hohenester Structure of a thrombospondin c-terminal fragment reveals a novel calcium core in the type 3 repeats EMBO J. 2004 1 11
29. G. Muller, A. Michel, and E. Altenburg Comp (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage Connect. Tissue Res. 39 4 1998 233 244
30. G. Newton, S. Weremowicz, C.C. Morton, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, and J. Lawler Characterization of human and mouse cartilage oligomeric matrix protein Genomics 24 3 1994 435 439
31. A. Oldberg, P. Antonsson, K. Lindblom, and D. Heinegard Comp (cartilage oligomeric matrix protein) is structurally related to the thrombospondins J. Biol. Chem. 267 31 1992 22346 22350
32. K.L. Posey, E. Hayes, R. Haynes, and J.T. Hecht Role of TSP-5/COMP in pseudoachondroplasia Int. J. Biochem. Cell Biol. 36 2004 1005 1012
33. R. Riessen, M. Fenchel, H. Chen, D.I. Axel, K.R. Karsch, and J. Lawler Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 21 1 2001 47 54
34. S. Schwartz, W.J. Kent, A. Smit, Z. Zhang, R. Baertsch, R.C. Hardison, D. Haussler, and W. Miller Human-mouse alignments with blastz Genome Res. 13 1 2003 103 107
35. R.K. Smith, L. Zunino, P.M. Webbon, and D. Heinegard The distribution of cartilage oligomeric matrix protein (comp) in tendon and its variation with tendon size, age and load Matrix Biol. 16 5 1997 255 271
36. L. Svensson, A. Aszodi, D. Heinegard, E.B. Hunziker, F.P. Reinholt, R. Fassler, and A. Oldberg Cartilage oligomeric matrix protein-deficient mice have normal skeletal development Mol. Cell. Biol. 22 12 2002 4366 4371
37. J. Thur, K. Rosenberg, D.P. Nitsche, T. Pihlajamaa, L. Ala-Kokko, D. Heinegard, M. Paulsson, and P. Maurer Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen i, ii, and ix J. Biol. Chem. 276 9 2001 6083 6092
38. S. Unger, and J.T. Hecht Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments Am. J. Med. Genet. 106 4 2001 244 250
39. W.F. Xie, X. Zhang, S. Sakano, V. Lefebvre, and L.J. Sandell Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by sox9 J. Bone Miner. Res. 14 5 1999 757 763
40. P. Zhang, S.A. Jimenez, and D.G. Stokes Regulation of human col9a1 gene expression. Activation of the proximal promoter region by sox9 J. Biol. Chem. 278 1 2003 117 123
41. G. Zhou, S. Garofalo, K. Mukhopadhyay, V. Lefebvre, C.N. Smith, H. Eberspaecher, and B. de Crombrugghe A 182 bp fragment of the mouse pro alpha 1(ii) collagen gene is sufficient to direct chondrocyte expression in transgenic mice J. Cell Sci. 108 Pt 12 1995 3677 3684